Cart
sales@molnova.com
CDC801
CAS No. 192819-27-5
CDC801( CDC-801 )
Catalog No. M26097 CAS No. 192819-27-5
CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 358 | Get Quote |
|
| 5MG | 560 | Get Quote |
|
| 10MG | 799 | Get Quote |
|
| 25MG | 1197 | Get Quote |
|
| 50MG | 1611 | Get Quote |
|
| 100MG | 2187 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCDC801
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
-
DescriptionCDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
-
In VitroThe more detailed information refer to the Compound 6b in the reference 1 (PMID:19256507).
-
In Vivo——
-
SynonymsCDC-801
-
PathwayApoptosis
-
TargetTNF
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number192819-27-5
-
Formula Weight408.454
-
Molecular FormulaC23H24N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (40.81 mM)
-
SMILESCOc1ccc(cc1OC1CCCC1)C(CC(N)=O)N1C(=O)c2ccccc2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hamilton KL,et al. DCEBIO stimulates Cl- secretion in the mouse jejunum. Am J Physiol Cell Physiol. 2006 Jan;290(1):C152-64.
molnova catalog
related products
-
Dihydrodehydrodiconi...
Dihydrodehydrodiconiferyl alcohol is the methanolic extract of Liriodendron tulipifera.
-
MOSLOFLAVONE
MOSLOFLAVONE showed promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 0.71 μM and ?7.8 μM respectively.
-
Certolizumab pegol
Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).
